MedPath

Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)

Conditions
Heparin-Induced Thrombocytopenia
Interventions
Other: Scoring 4Ts and Chong scale
Other: Blood draw
Registration Number
NCT00946400
Lead Sponsor
Medstar Health Research Institute
Brief Summary

The purpose of this study is to evaluate a scoring tool to help determine the presence of Heparin Induced Thrombocytopenia (HIT), which is an adverse reaction to heparin. We hypothesize that this scoring tool will be very useful in excluding patients who are suspected of having HIT.

Detailed Description

HIT is an immune response to heparin that can result in thrombogenic thrombocytopenia. It is often a difficult diagnosis to make, and its diagnosis is dependent upon both clinical and serologic criteria. Due to this ambiguity, increased testing and treatment may occur until serologic test results return. Recently, scoring tools have been developed to assist with the diagnosis of this disease. However, these scoring tools have yet to be validated. Thus, we plan to conduct a prospective, observational study to validate two scoring tools, the 4Ts and the Chong scale, in the diagnosis of HIT.

In order to validate these scoring tools, two physicians will independently score the 4Ts and the Chong scale for all patients suspected of having HIT. These patients will be identified if a physician has ordered HIT antibody testing using the enzyme immunoassay (EIA) method. Confirmatory testing with a serotonin release assay (SRA) will also be performed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patients with suspected HIT.
Exclusion Criteria
  • None.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Suspected HITBlood drawThose who are clinically suspected of having HIT will be enrolled in this study.
Suspected HITScoring 4Ts and Chong scaleThose who are clinically suspected of having HIT will be enrolled in this study.
Primary Outcome Measures
NameTimeMethod
To validate the 4Ts as a pretest probability tool for HIT.End of study.
To validate the Chong scale as a tool to determine the post-test probability for HIT.End of study.
Secondary Outcome Measures
NameTimeMethod
To determine the inter-rater variability for scoring the Chong scale.End of study.
To determine the inter-rater variability for scoring the 4Ts.End of study.

Trial Locations

Locations (1)

Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath